Overview

Assessment of Insulin Glargine in Type 2 Patients for Good Glycemic Control

Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
Primary objective: - To observe the efficacy of the forced titration to reach good glycemic control in Lantus treated patients Secondary objectives: - To assess the forced titration on physician and patient satisfaction - To evaluate the impact of training tools by means of patient profile
Phase:
Phase 4
Details
Lead Sponsor:
Sanofi
Treatments:
Insulin
Insulin Glargine
Insulin, Globin Zinc